The company is focused on developing and commercializing cytisinicline, a smoking cessation aid that has been approved and marketed in Central and Eastern Europe, to help people overcome nicotine addiction globally. Achieve Life Sciences is dedicated to addressing the global smoking health crisis and making cytisinicline widely available as a treatment option. As a specialty pharmaceutical company, Achieve Life Sciences is committed to advancing the development of cytisinicline as a smoking cessation aid.